MedTech Industry Dynamics
MedTech Industry Dynamics
Centinel Spine has received FDA approval for two-level use of its prodisc C Nova cervical total disc replacement device, making it the third prodisc cervical device approved for both one- and two-level use and further expanding the company’s Match-the-Disc portfolio.
Read MoreSiemens Healthineers has integrated Vuze guidance software into its Cios Spin C-arm system for trackerless spinal surgery guidance, enabling K-wire placement for pedicle screws with up to 96.7% accuracy on artificial spine models without external tracking hardware.
Read MoreVB Spine has entered into a definitive agreement to acquire exclusive rights to Augmedics’ CT-to-fluoroscopy technology for spine applications, expanding its augmented reality navigation platform following the acquisition of the xvision Spine System in April.
Read MoreVB Spine has agreed to acquire the SpineHawk intraoperative visualization platform from Robotron Surgical Technologies, adding AI-enabled spinal imaging capabilities to its technology portfolio.
Read MoreXtant Medical has introduced nanOss Strata, a next-generation synthetic bone graft engineered to better mimic human bone and support improved integration during orthopedic and spinal procedures.
Read MoreZavation Medical Products has launched NanoPrime, a hybrid PEEK–titanium implant material designed to improve biological integration while retaining mechanical and imaging advantages.
Read Moreicotec has received FDA clearance for its CMORE CT System, expanding the company’s radiolucent BlackArmor implant technology to posterior stabilization procedures in the cervicothoracic spine.
Read MoreNavJam has granted Ruthless Spine exclusive worldwide rights to distribute its patented spinal surgery instruments, expanding access to integrated, radiation-sparing navigation technologies.
Read MoreAmber Implants has appointed Vincent Gardès as Chief Executive Officer to guide its transition into commercialization following FDA clearance of the VCFix® Spinal System, with a U.S. launch planned for 2026.
Read MoreAurora Spine has introduced a new biologics division offering allograft-based bone graft products designed to support spinal fusion procedures and integrate with the company’s existing implant systems.
Read More
